Losartan improves the therapeutic effect of metronomic cyclophosphamide in triple negative mammary cancer models.

Oncotarget · 2020 · PMC7429183 · PMID 32850009

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

marginally significantno p-value reported

On the contrary, in the M-406 model, there was a marginally significant decrease in Tregs and a significant increase in Th17 cells in the combined treated group.

also in 26,082 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.